MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumorsMichael Kilian, Michael Platten|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 14
OS06.4A Identification of T cell receptors targeting ZFTA-RELA fusion-positive ependymomaNiklas Kehl, Michael Platten, M Friedrich et al.|Neuro-Oncology|2021Cited by 0
Discovery of Tumor Reactive T Cell Receptors in Newly Diagnosed Multiple MyelomaMirco Friedrich, Marc S. Raab, Niklas Kehl et al.|Blood|2022Cited by 0
P-482 Dietary habits correlate with myeloma pathogenesis and treatment outcome in multiple myelomaLilli Sester, Marc S. Raab, Anna Katharina Gambihler et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 0
P-151 Dietary Oleic Acid Influences the Myeloma Immune Microenvironment and Improves Clinical OutcomesLilli Sester, Marc‐Steffen Raab, Gernot Poschet et al.|Clinical Lymphoma Myeloma & Leukemia|2024Cited by 0